NEA Management Company’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $11.3M | Hold |
|
|||||
|
2024
Q4 | $10.2M | Hold |
|
|||||
|
2024
Q3 | $10.2M | Hold |
|
|||||
|
2024
Q2 | $11.6M | Hold |
|
|||||
|
2024
Q1 | $18.6M | Buy |
|
|||||
|
2023
Q4 | $2.49M | Hold |
|
|||||
|
2023
Q3 | $2.67M | Hold |
|
|||||
|
2023
Q2 | $2.86M | Buy |
|
|||||
|
2023
Q1 | $1.22M | Hold |
|
|||||
|
2022
Q4 | $1.98M | Sell |
|
|||||
|
2022
Q3 | $2.46M | Hold |
|
|||||
|
2022
Q2 | $2.99M | Hold |
|
|||||
|
2022
Q1 | $4.31M | Buy |
|
|||||
|
2021
Q4 | $2.06M | Hold |
|
|||||
|
2021
Q3 | $4.46M | Hold |
|
|||||
|
2021
Q2 | $5.22M | Hold |
|
|||||
|
2021
Q1 | $10.1M | Hold |
|
|||||
|
2020
Q4 | $8.71M | Buy |
|
|||||
|
2020
Q3 | $1.05M | Hold |
|
|||||
|
2020
Q2 | $1.4M | Hold |
|
|||||
|
2020
Q1 | $946K | Hold |
|
|||||
|
2019
Q4 | $1.83M | Hold |
|
|||||
|
2019
Q3 | $1.48M | Hold |
|
|||||
|
2019
Q2 | $2.57M | Buy |
|
|||||
|
2019
Q1 | $934K | Hold |
|
|||||
|
2018
Q4 | $852K | Hold |
|
|||||
|
2018
Q3 | $26M | Sell |
|
|||||
|
2018
Q2 | $7.24M | Hold |
|
|||||
|
2018
Q1 | $7.88M | Hold |
|
|||||
|
2017
Q4 | $11.4M | Hold |
|
|||||
|
2017
Q3 | $13.7M | Buy |
|